These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Neuroendocrine tumors. Biotherapy. Plöckinger U; Wiedenmann B Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):145-62. PubMed ID: 17382270 [TBL] [Abstract][Full Text] [Related]
27. [Gastrointestinal neuroendocrine neoplasias: novel individualized therapeutic strategies]. Pape UF; Pascher A; Arsenic R; Ezziddin S; Jann H; Pavel ME; Wiedenmann B Dtsch Med Wochenschr; 2011 Sep; 136(36):1801-6. PubMed ID: 21882138 [No Abstract] [Full Text] [Related]
28. [Somatostatin analogues for the treatment of gastro-entero-pancreatic neuroendocrine tumours]. Uomo G; Germano D; Rabitti PG Minerva Endocrinol; 2001 Dec; 26(4):225-9. PubMed ID: 11782707 [TBL] [Abstract][Full Text] [Related]
29. Medical treatment of endocrine gastroenteropancreatic tumors. Tomassetti P; Campana D; Nori F; Piscitelli L; Salomone L; Pezzilli R; Corinaldesi R JOP; 2006 Jan; 7(1):145-9. PubMed ID: 16407637 [No Abstract] [Full Text] [Related]
30. The management of neuroendocrine tumours: current and future medical therapy options. Oberg KE Clin Oncol (R Coll Radiol); 2012 May; 24(4):282-93. PubMed ID: 21907552 [TBL] [Abstract][Full Text] [Related]
31. [Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies]. Auernhammer CJ; Jauch KW; Hoffmann JN Zentralbl Chir; 2009 Sep; 134(5):410-7. PubMed ID: 19757340 [TBL] [Abstract][Full Text] [Related]
32. New treatment strategies in advanced neuroendocrine tumours. Walter T; Brixi-Benmansour H; Lombard-Bohas C; Cadiot G Dig Liver Dis; 2012 Feb; 44(2):95-105. PubMed ID: 21983252 [TBL] [Abstract][Full Text] [Related]
33. Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future Perspectives. Herrera-Martínez AD; Hofland J; Hofland LJ; Brabander T; Eskens FALM; Gálvez Moreno MA; Luque RM; Castaño JP; de Herder WW; Feelders RA Drugs; 2019 Jan; 79(1):21-42. PubMed ID: 30560479 [TBL] [Abstract][Full Text] [Related]
34. An update on gastroenteropancreatic neuroendocrine tumors. Cives M; Strosberg J Oncology (Williston Park); 2014 Sep; 28(9):749-56, 758. PubMed ID: 25224471 [TBL] [Abstract][Full Text] [Related]
35. [Neuroendocrine tumours of the gastrointestinal tract]. Plöckinger U; Wiedenmann B Z Gastroenterol; 2004 Jun; 42(6):517-27. PubMed ID: 15190448 [TBL] [Abstract][Full Text] [Related]
36. Advances in the systemic treatment of pancreatic neuroendocrine tumors. Yalcin S Cancer Treat Rev; 2011 Apr; 37(2):127-32. PubMed ID: 20705397 [TBL] [Abstract][Full Text] [Related]
37. [Neurendocrine tumours of the appendix, colon and rectum: current surgical aspects]. Rosato L; De Tomaa G; Mondini G; Bertone P; Fornari F; Orlassino R Chir Ital; 2007; 59(4):445-52. PubMed ID: 17966763 [TBL] [Abstract][Full Text] [Related]
38. Current Chemotherapy Use in Neuroendocrine Tumors. Chan DL; Singh S Endocrinol Metab Clin North Am; 2018 Sep; 47(3):603-614. PubMed ID: 30098718 [TBL] [Abstract][Full Text] [Related]
39. [Mid gut neuroendocrine tumors: News on medical treatment]. Dior M; Dreanic J; Prieux-Klotz C; Brieau B; Brezault C; Coriat R Presse Med; 2017 Jan; 46(1):4-10. PubMed ID: 28089247 [TBL] [Abstract][Full Text] [Related]
40. Somatostatin-receptor mediated diagnosis and treatment in gastrointestinal neuroendocrine tumours (GEP-NET's). Oberg K Rocz Akad Med Bialymst; 2005; 50():62-8. PubMed ID: 16358941 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]